Publikationer 2016 / Kurt Boman

 

  1. Ängerud KH, Boman K, Ekman I, Brännström M. Areas for quality improvements in heart failure care: quality of care from the patient's perspective. Scand J Caring Sci. 2016 Nov 18. doi: 10.1111/scs.12404. [Epub ahead of print].
  2. Persson SE, Boman K, Wanhainen A, Carlberg B, Arnerlöv C. Decreasing prevalence of abdominal aortic aneurysm and changes in cardiovascular risk factors. J Vasc Surg. 2016 Oct 25. pii: S0741-5214(16)31129-6. doi: 10.1016/j.jvs.2016.08.091. [Epub ahead of print].
  3. Mancusi C, Gerdts E, de Simone G, Midtbø H, Lønnebakken MT, Boman K, Wachtell K, Dahlöf B, Devereux RB.] Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study. Blood Press. 2016 Nov 24:1-6. [Epub ahead of print.
  4. Hodges GW, Bang CN, Eugen-Olsen J, Olsen MH, Boman K, Ray S, Gohlke-Bärwolf C, Kesäniemi YA, Jeppesen JL, Wachtell K. SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis. Can J Cardiol. 2016 Dec;32(12):1462-1469. doi: 10.1016/j.cjca.2016.04.012.
  5. Björck L, Rosengren A, Winkvist A, Capewell S, Adiels M, Bandosz P, Critchley J, Boman K, Guzman-Castillo M, O'Flaherty M, Johansson I. Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study. PLoS One. 2016 Aug 4;11(8):e0160474. doi: 10.1371/journal.pone.0160474.
  6. Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K. Circulation. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS). 2016 Aug 9;134(6):455-68. doi: 10.1161/CIRCULATIONAHA.115.021213
  7. McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859.
  8. Blyme A, Asferg C, Nielsen OW, Boman K, Gohlke-Bärwolf C, Wachtell K, Olsen MH. Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis. Scand Cardiovasc J. 2016 Jun;50(3):138-45. doi: 10.3109/14017431.2016.1151928.
  9. Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U. Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study. BMC Cardiovasc Disord. 2016 Feb 13;16:39. doi: 10.1186/s12872-016-0221-7.
  10. Rautio A, Boman K, Eriksson JW, Svensson MK. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up. Diab Vasc Dis Res. 2016 May;13(3):183-91. doi: 10.1177/1479164115618516.
  11. Markgren R, Brännström M, Lundgren C, Boman K. Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: a substudy of a randomised trial. BMJ Support Palliat Care. 2016 Jan 20. pii: bmjspcare-2015-000894. doi: 10.1136/bmjspcare-2015-000894. [Epub ahead of print].

Posters, abstract

  1. A description of unselected patients with heart failure:a Swedish population-based study.J.Stålhammar, K.Boman, M.Olofsson, K. Lindmark, R. Lahoz, S.Corda, V.Wintzell, R.Linder, A. Gondos,G. Wikström, Heart Failure Congress i Florence, maj 2016 (poster).
  2. Recent trends in diagnostic work-up among unselected patients newly diagnosed with heart failure: a Swedish population-based study. J.Stålhammar, K.Boman, M.Olofsson, K. Lindmark, R. Lahoz, S.Corda, V.Wintzell, R.Linder, A. Gondos,G. Wikström, Heart Failure Congress i Florence, maj 2016(poster).
  3. Exposure to heart failure treatments in newly diagnosed patients in Sweden. G. Wikström, K.Boman, M.Olofsson, K. Lindmark, R. Lahoz, S.Corda, V.Wintzell, R.Linder, A. Gondos, J. Stålhammar,Heart Failure Congress i Florence, maj 2016(poster).
  4. Predicting hospitalizations using ST2. Mona Olofsson,BMA/Med.Dr, Kurt Boman,senior professor, Heart Failure Congress i Florence, maj 2016(poster).
  5. ST2 is an independent predictor of all-cause mortality in elderly patients. Mona Olofsson,BMA/Med.Dr, Kurt Boman,senior professor, Heart Failure Congress i Florence, maj 2016(poster).
  6. ST2 is an independent predictor of all-cause mortality in elderly patients. Mona Olofsson, BMA/Med.Dr, Kurt Boman, senior professor, Kardiovaskulära vårmötet,  april 2016 (poster).

Handledning:

Aslak Rautio disputerad mars 2016

 

Föreläsningar, inbjuden föreläsare 2016

  1. Kardiovaskulär sjukdom i brett perspektiv Stockholm januari 2016.
  2. Telemedicin vid warfarinbehandling, Stockholm 4 Februari 2016, Equalismöte
  3. Fysisk aktivitet vid hjärtkärl-sjukdom, Skellefteå.
  4. HjärtLungföreningen Västerbotten, Föreläsning om hjärtsvikt, förmaksflimmer. Lycksele,   Vindeln.

 

Planerade studier 2017:

  1. Fortsatta studier på järnbrist hos patienter med svår hjärtsvikt och hos patienter med misstänkt hjärtsvikt i primärvården.
  2. Fortsatt utvärdering av patienters och närståendes vårdbehov i HOPP-projektet.
  3. Fortsatta studier i internationella  LIFE- ECHO projektet (högt blodtryck och vänsterkammarhypertrofi).
  4. Fortsatta i internationella SEAS-projektet (aortasteons).
  5. Fortsatt utveckling inom telemedicin. Ansökan gjord till Tillväxtverket, som godkänt projekt. Inväntar beslut från universitet.
  6. Fortsattutvärdering av biomarkörerna ST2 och galectin 3 i HOPP- och Heimdall-projekten.
  7. Fortsatta studier i ORIGIN-studien med Aslak Rautio.
  8. Fortsatt utvärdering av hjärtsvikt i Västerbotten. Pygargus-projektet.

 

Publikationer 2016 / Jan-Håkan Jansson

  1. Nathan O. Stitziel, M.D., Ph.D., Kathleen E. Stirrups, Ph.D., Jan-Hakan Jansson, M.D., Ph.D. et al. Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med. 2016 Mar 2. [Epub ahead of print] PubMed PMID: 26934567.
  2. Olofsson M, et al., Predictors for hospitalizations in elderly patients with clinical symptoms of heart failure: A 10-year observational primary healthcare study, Journal of Clinical Gerontology & Geriatrics (2016), http://dx.doi.org/10.1016/j.jcgg.2015. 11.001
  3. Eriksson M(1), Forslund AS(2), Jansson JH(3), Söderberg S(4), Wennberg M(5), Eliasson M(6). Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population: the northern Sweden MONICA study 1994 to 2014. Eur Heart J. 2016 Mar 2. pii: ehw052. [Epub ahead of print]
  4. Marcus Lind, Lars Johansson, Torbjörn K. Nilsson, Jan-Håkan Jansson. High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment. Clin Chem Lab Med. 2016 Jun 11. pii: /j/cclm.ahead-of-print/cclm-2016-0092/cclm-2016-0092.xml. doi: 10.1515/cclm-2016-0092. [Epub ahead of print]
  5. Andersson J(1), Wennberg P(2), Lundblad D(3), Escher SA(4), Jansson JH(5). Diabetes mellitus, high BMI and low education level predict sudden cardiac death  within 24 hours of incident myocardial infarction. Eur J Prev Cardiol. 2016 Nov;23(17):1814-1820. Epub 2016 Jul 19.
  6. Del Gobbo LC1, Imamura F2, Aslibekyan S3, Marklund M4, Virtanen JK5, Wennberg M6, Yakoob MY1, Chiuve SE7, Dela Cruz L8, Frazier-Wood AC9, Fretts AM10, Guallar E11, Matsumoto C12, Prem K13, Tanaka T14, Wu JH15, Zhou X16, Helmer C17, Ingelsson E18, Yuan JM19, Barberger-Gateau P17, Campos H20, Chaves PH21, Djoussé L22, Giles GG8, Gómez-Aracena J23, Hodge AM8, Hu FB24, Jansson JH6, Johansson I25, Khaw KT26, Koh WP27, Lemaitre RN28, Lind L29, Luben RN26, Rimm EB24, Risérus U4, Samieri C17, Franks PW30, Siscovick DS31, Stampfer M24, Steffen LM16, Steffen BT16, Tsai MY32, van Dam RM33, Voutilainen S5, Willett WC24, Woodward M34, Mozaffarian D35; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCe). ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med. 2016 Aug 1;176(8):1155-66. doi: 10.1001/jamainternmed.2016.2925.
  7. Jakobsdottir J1, van der Lee SJ2, Bis JC3, Chouraki V4,5, Li-Kroeger D6,7, Yamamoto S6,7,8, Grove ML9, Naj A10, Vronskaya M11, Salazar JL6, DeStefano AL5,12, Brody JA3, Smith AV1,13, Amin N2, Sims R11, Ibrahim-Verbaas CA2,14, Choi SH5,12, Satizabal CL4,5, Lopez OL15, Beiser A4,5,12, Ikram MA2,14,16, Garcia ME17, Hayward C18,19, Varga TV20, Ripatti S21,22, Franks PW20,23,24, Hallmans G25, Rolandsson O26, Jansson JH23,27, Porteous DJ19,28, Salomaa V29, Eiriksdottir G1, Rice KM30, Bellen HJ6,7,8,31, Levy D5,32,4, Uitterlinden AG2,33, Emilsson V1,34, Rotter JI35, Aspelund T1,36; Cohorts for Heart and Aging Research in Genomic Epidemiology consortium; Alzheimer’s Disease Genetic Consortium; Genetic and Environmental Risk in Alzheimer’s Disease consortium, O'Donnell CJ5,32, Fitzpatrick AL37,38, Launer LJ17, Hofman A2, Wang LS39, Williams J11, Schellenberg GD39, Boerwinkle E9,40, Psaty BM3,37,41,42, Seshadri S4,5, Shulman JM6,7,8, Gudnason V1,13, van Duijn CM2 Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease. PLoS Genet. 2016 Oct 20;12(10):e1006327. doi: 10.1371/journal.pgen.1006327. eCollection 2016
  8. Kanoni S, Masca NG, Stirrups KE, Varga TV, Warren HR, Scott RA, Southam L, Zhang W, Yaghootkar H, Müller-Nurasyid M, Couto Alves A, Strawbridge RJ, Lataniotis L, An Hashim N, Besse C, Boland A, Braund PS, Connell JM, Dominiczak A, Farmaki AE, Franks S, Grallert H, Jansson JH, Karaleftheri M, Keinänen-Kiukaanniemi S, Matchan A, Pasko D, Peters A, Poulter N, Rayner NW, Renström F, Rolandsson O, Sabater-Lleal M, Sennblad B, Sever P, Shields D, Silveira A, Stanton AV, Strauch K, Tomaszewski M, Tsafantakis E, Waldenberger M,  Blakemore AI, Dedoussis G, Escher SA, Kooner JS, McCarthy MI, Palmer CN; Wellcome Trust Case Control Consortium., Hamsten A, Caulfield MJ, Frayling TM, Tobin MD, Jarvelin MR, Zeggini E, Gieger C, Chambers JC, Wareham NJ, Munroe PB, Franks PW,  Samani NJ, Deloukas P. Analysis with the exome array identifies multiple new independent variants in lipid loci. Hum Mol Genet. 2016 Jul 27. pii: ddw227. [Epub ahead of print] PubMed PMID: 27466198.
  9. Yang F(1), Pedersen NL(2,)(3), Ye W(2), Liu Z(2), Norberg M(4), Forsgren L(5),Trolle Lagerros Y(6,)(7), Bellocco R(2,)(8), Alfredsson L(9), Knutsson A(10),Jansson JH(11), Wennberg P(12), Galanti MR(13,)(14), Lager AC(13,)(14), Araghi M(13), Lundberg M(13), Magnusson C(13,)(14), Wirdefeldt K(2,)(15). Moist smokeless tobacco (Snus) use and risk of Parkinson's disease. Int J Epidemiol. 2016 Dec 10. pii: dyw294. [Epub ahead of print]
  10. Wennberg M, Jansson JH, Norberg M, Skerfving S, Strömberg U, Wiklund PG, Bergdahl IA. Fish consumption and risk of stroke: a second prospective case-control study from northern Sweden. Nutr J. 2016
Stöd vår forskning redan idag

Så hjälper du till

Stiftelsen vill inspirera och stödja yngre men även äldre läkare, sjuksköterskor, apotekare med flera till att forska inom områdena medicin och omvårdnad inom Skellefteå sjukvård (kommunerna Skellefteå och Norsjö).

Postgiro & Bankgiro

Stöd vår verksamhet genom att sätta in pengar på följande Post- och Bankgiro:

Stiftelsens postgiro 444 81 29-9
Stiftelsens bankgiro 710-9721
Stiftelsens swish 1233351574

Dela vår hemsida

Hjälp vår stiftelse och våra forskare genom att sprida vår sida vidare via sociala medier.
Information om cookies